49. Halman MH,Worth JL, Sanders KM, et al. Anticonvulsant use in the treatment of manic syndrome in patients with HIV-1 infection. J Neuropsychiatry Clin Neurosci 1993; 5: 430-434.
50. Hamers F. and Downs A. HIV in central and eastern Europe. The Lancet. – 2003. – Vol. 361. – Р. 1035-44, 22March.
51. Horwath E, Kramer M, Cournos F, et al. Clinical presentations of AIDS and HIV infection in state psychiatric facilities. Hosp Comm Psychiatry 1989; 40: 502-514.
52. Jacobsberg LB, Perry S. Medical management of AIDS patients: psychiatric disturbances. Med Clin North Am 1992; 76: 99-106.
53. Janicak PG. Psychopharmacotherapy in the HIV-infected patient. Psychiatric Ann 1995; 25 (10): 609-613.
54. Jobe ТН. Neuropsychiatry of HIV disease. In: Flaherty J, Davis JM, Janicak PG, eds. Psychiatry: diagnosis and therapy. New York: Appleton and Lange, 1993.
55. Justice A.C., McGinnis K.A., Atkinson J.H. et al. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study // AIDS. – 2004. – Vol. 18, Suppl.1. – P. 49–59.
56. Kalichman S (1995). Understanding AIDS: A guide for mental health professionals. American Psychological Association. Washington DC, USA.
57. Kalichman S.C., Heckman T., Kochman A., Sikkema K., Bergholte J. Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS // Psychiatr. Serv. – 2000. – Vol. 51. – P. 903–907.
58. Kalichman SC, KellkyJA, Johnson J, et al. Factors associated with risk for human immunodefciency versus (HIV) infection among chronically mentally ill adults. Am J Psychiatry 1993; 151:121-127.
59. King M.B. AIDS, HIV and Mental Health. Cambridge: Cambridge niversity Press, 1993.
60. King M.B. Psychological status of 192 out-patients with HIV infection and AIDS // Br. J. Psychiatry. – 1989. – Vol. 154. – P. 237–242.
61. Lishman’s organic psychiatry: a textbook of neuropsychiatry /A. David et al. (Eds.). 4th Edition. Part 2. – 2009. – Ch. 7. – P. 397–472.
62. Low-Beer S., Clan K., Hogg R.S. et al. Depressive symptoms decline among persons on HIV protease inhibitors // J. Acquired Immune Defc. Syndrome. – 2000. – Vol. 23. – P. 295–301.
63. Lyketsos C.G., Hanson A.L., Fishman M. et al. Screening for psychiatric disorders in an HIV medical clinic: the importance of a psychiatric presence // Int. J. Psychiatry. Med. – 1994. – P. 103– 113.
64. Maj M, Janssen R, Starace F, et al. WHO neuropsychiatry AIDS study, cross-sectional phase 1. Arch Gen Psychiatry 1994; 51: 39-49.
65. Marzuk P.M. Suicidal behavior and HIV illness // Int. Rev. Psychiatry. 1991. – Vol. 3. – P. 365–371.
66. Marzuk P.M., Tierney H., Tardif K. et al. Increased risk of suicide in persons with AIDS // J. Am. Med. Association. – 1988. – Vol. 259. – P. 1333–1337.
67. Maschke M., Kastrup O., Esser S. et al. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART) // J. Neurology, Neurosurgery and Psychiatry. – 2000. – Vol. 69. – P. 376–380.
68. Menza MA, Murray GB, Holmes VF, et al. Decreased extrapyramidal symptoms with intravenous haloperidol. J Clin Psychiatry 1987; 48:278-280.
69. Navia B.A., Lee P.L., Chang L. et al. Metabolite changes in the basal ganglia provide a signature for the AIDS dementia complex: a multicenter proton magnetic resonance study // Neurology. – 1999. – Vol. 52. – P. (S2): A253.
70. Ofah C.E., Turnbull I.W. The imaging appearances of intracranial CNS infections in adult HIV and AIDS patients // Clin. Radiol. – 2006. – Vol. 61. – P. 393–401.
71. Ostrow D, Grant I, Atkinson H. Assessment and management of AIDS patients with neuropsy-chiatric disturbances. J Clin Psychiatry 1988; 49 (Suppl): 14-22.
72. Patrick D., Tyndall M., Cornelisse P. et al. Incidence of hepatitis C virus among drug users duringan outbreak of HIV infection. // Canadian Medical Association Journal. – 2001. – Vol. 165. – Р. 889–895.
73. Pence B.W., Miller W.C., Whetten K. et al. Mental disorders common among HIV-infected patients // J. Acquired Immune Defcit Syndrome. – 2006. – Vol. 42. – P. 298–306.
74. Perkins D.O., Stern R.A., Golden R.N. et al. Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic // Am. J. Psychiatry. – 1994. – Vol. 151. – P. 223–236.
75. Preskorn S, Janicak PG, Davis JM, Ayd F Jr. Advances in the psychopharmacotherapy of depressive disorders. In: Janicak PG, ed.
76. Principles and practice of psychopharmacotherapy. Update, Vol 1 (3). Baltimore: Williams & Wilkins, 1995.
77. Regier D., Farmer M., Rae D. et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association. – 1990. – Vol. 26 (19). – Р. 2511-2518.
78. REPSSI (2004). About REPSSI: State of the initiative, 2003. Regional Psychosocial Support Initiative.initiativestate.htm